Neurogene Inc.
NGNE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404644
In the last 90 days, Neurogene Inc. insiders filed 0 open-market purchases and 2 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $544.4M in total; no superinvestor holds it.
Holders of 5% or more of NGNE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Neurogene Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| RTW Investments, LP | 13G/A | 9.99%1.50M shares | – | Feb 14, 20251 filing | Feb 14, 2025 | SEC |
| Redmile Group, LLC | 13G/A | 9.90%1.48M shares | – | Feb 14, 20251 filing | Feb 14, 2025 | SEC |
| Casdin Capital, LLC | 13G/A | 8.70%1.30M shares | – | Feb 14, 20251 filing | Feb 14, 2025 | SEC |
| Baker Bros. Advisors LP | 13G/A | 7.00%991.8K shares | −2.96 ppfrom 9.96% | May 15, 20252 filings | Aug 14, 2025 | SEC |
| BlackRock, Inc. | 13G/A | 6.80%1.01M shares | – | Apr 23, 20251 filing | Apr 23, 2025 | SEC |
| Trails Edge Capital Partners, LP | 13G | 5.10%785.0K shares | New | Dec 15, 20251 filing | Dec 15, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
11 Schedule 13D and 13G filings on Neurogene Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 15, 20256:00 PM ET | Trails Edge Capital Partners, LPand 2 others | 13G | 5.10%785.0K shares | New | Dec 8, 2025 | SEC |
| Aug 14, 20255:07 PM ET | Commodore Capital LPand 1 other | 13G/A | 3.00%427.9K shares | –Below 5% | Jun 30, 2025 | SEC |
| Aug 14, 20254:27 PM ET | Baker Bros. Advisors LPand 3 others | 13G/A | 7.00%991.8K shares | −2.96 ppfrom 9.96% | Jun 30, 2025 | SEC |
| May 15, 20254:19 PM ET | Baker Bros. Advisors LPand 3 others | 13G | 9.96%1.49M shares | New | Mar 31, 2025 | SEC |
| May 12, 202510:36 AM ET | FMR LLCand 1 other | 13G/A | 3.10%462.9K shares | –Below 5% | Mar 31, 2025 | SEC |
| Apr 23, 20258:57 PM ET | BlackRock, Inc. | 13G/A | 6.80%1.01M shares | – | Mar 31, 2025 | SEC |
| Feb 14, 20258:01 PM ET | Redmile Group, LLCand 2 others | 13G/A | 9.90%1.48M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 20254:31 PM ET | Great Point Partners LLCand 2 others | 13G/A | 2.98%442.8K shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 20254:00 PM ET | Casdin Capital, LLCand 3 others | 13G/A | 8.70%1.30M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 202511:34 AM ET | Janus Henderson Group PLC | 13G/A | 0.00%0 shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 20259:00 AM ET | RTW Investments, LPand 1 other | 13G/A | 9.99%1.50M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Neurogene Inc. shares.
No Form 144 notices for Neurogene Inc. are on file.